EP0603314A4 - Chemical compounds. - Google Patents

Chemical compounds.

Info

Publication number
EP0603314A4
EP0603314A4 EP9292920317A EP92920317A EP0603314A4 EP 0603314 A4 EP0603314 A4 EP 0603314A4 EP 9292920317 A EP9292920317 A EP 9292920317A EP 92920317 A EP92920317 A EP 92920317A EP 0603314 A4 EP0603314 A4 EP 0603314A4
Authority
EP
European Patent Office
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP9292920317A
Other versions
EP0603314A1 (en
Inventor
Robert Michael Demarinis
Francis Richard Pfeiffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0603314A1 publication Critical patent/EP0603314A1/en
Publication of EP0603314A4 publication Critical patent/EP0603314A4/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP9292920317A 1991-09-12 1992-09-11 Chemical compounds. Ceased EP0603314A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9119467 1991-09-12
GB919119467A GB9119467D0 (en) 1991-09-12 1991-09-12 Chemical compounds
PCT/US1992/007694 WO1993004686A1 (en) 1991-09-12 1992-09-11 Chemical compounds

Publications (2)

Publication Number Publication Date
EP0603314A1 EP0603314A1 (en) 1994-06-29
EP0603314A4 true EP0603314A4 (en) 1994-08-24

Family

ID=10701273

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9292920317A Ceased EP0603314A4 (en) 1991-09-12 1992-09-11 Chemical compounds.

Country Status (5)

Country Link
EP (1) EP0603314A4 (en)
JP (1) JPH06510545A (en)
AU (1) AU2654792A (en)
GB (1) GB9119467D0 (en)
WO (1) WO1993004686A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007353A1 (en) * 1997-08-05 1999-02-18 The Mount Sinai School Of Medicine Of The City University Of New York USE OF α1A-ADRENERGIC RECEPTOR ANTAGONISTS IN GLAUCOMA THERAPY
PL348817A1 (en) * 1998-12-14 2002-06-17 Cellegy Pharmaceuticals Compositions and methods for the treatment of anorectal disorders
PA8557501A1 (en) 2001-11-12 2003-06-30 Pfizer Prod Inc BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
CA2509413C (en) 2002-12-20 2012-05-01 Glaxo Group Limited Benzazepine derivatives for the treatment of neurological disorders
PA8591801A1 (en) 2002-12-31 2004-07-26 Pfizer Prod Inc BENZAMID INHIBITORS OF THE P2X7 RECEIVER.
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
DE602004005033T2 (en) 2003-05-12 2007-08-09 Pfizer Products Inc., Groton BENZAMIDINHIBITORS OF THE P2X7 RECEPTOR
CA2543287A1 (en) * 2003-10-23 2005-05-06 F.Hoffmann-La Roche Ag Benzazepine derivatives as mao-b inhibitors
DK1720836T3 (en) 2004-02-25 2014-05-05 Lilly Co Eli 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO [D] AZEPINES AS 5-HT2C RECEPTOR AGONISTS
WO2006003500A1 (en) 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
WO2007028132A2 (en) 2005-09-01 2007-03-08 Eli Lilly And Company 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
JP5237810B2 (en) * 2005-09-01 2013-07-17 イーライ リリー アンド カンパニー 6-Substituted 2,3,4,5-tetrahydro-1H-benzo [d] azepine as a 5-HT2C receptor agonist
AU2006287202B2 (en) 2005-09-01 2013-01-24 Eli Lilly And Company 6-arylalkylamino- 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2c receptor agonists
PT1924560E (en) * 2005-09-01 2009-10-23 Lilly Co Eli 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285287A2 (en) * 1987-03-23 1988-10-05 Smithkline Beecham Corporation 3-Benzazepine compounds for use in treating gastrointestinal motility disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483185A (en) * 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
ZA792785B (en) * 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4683229A (en) * 1986-03-17 1987-07-28 Smithkline Beckman Corporation 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285287A2 (en) * 1987-03-23 1988-10-05 Smithkline Beecham Corporation 3-Benzazepine compounds for use in treating gastrointestinal motility disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LADD, DAVID L.; WEINSTOCK, JOSEPH; WISE, MARGARET; GESSNER, GEORGE W.; SAWYER, JOHN L.; FLAIM, KATHRYN E.: "Synthesis and dopaminergic binding of 2-aryldopamine analogs: phenethylamines, 3-benzazepines, and 9-(aminomethyl)fluorenes", JOURNAL OF MEDICINAL CHEMISTRY., vol. 29, no. 10, WASHINGTON US, pages 1904 - 1912, XP002031848, DOI: doi:10.1021/jm00160a018 *
See also references of WO9304686A1 *

Also Published As

Publication number Publication date
GB9119467D0 (en) 1991-10-23
JPH06510545A (en) 1994-11-24
AU2654792A (en) 1993-04-05
EP0603314A1 (en) 1994-06-29
WO1993004686A1 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
GB9109557D0 (en) Chemical compounds
GB9103862D0 (en) Chemical compounds
GB9105152D0 (en) Chemical compounds
EP0603314A4 (en) Chemical compounds.
GB9103770D0 (en) Chemical compounds
GB9100431D0 (en) Chemical compounds
EP0653937A4 (en) Chemical compounds.
EP0536310A4 (en) Chemical compounds.
EP0677041A4 (en) Chemical compounds.
GB9110507D0 (en) Chemical compounds
GB9100637D0 (en) Chemical compounds
GB9106350D0 (en) Chemical compounds
GB9100441D0 (en) Chemical compounds
GB9100432D0 (en) Chemical compounds
GB9104888D0 (en) Chemical compounds
GB9103894D0 (en) Chemical compounds
GB9100427D0 (en) Chemical compounds
GB9105202D0 (en) Chemical compounds
GB9102725D0 (en) Chemical compounds
GB9102690D0 (en) Chemical compounds
GB9102188D0 (en) Chemical compounds
GB9106339D0 (en) Chemical compounds
GB9100628D0 (en) Chemical compounds
GB9107328D0 (en) Chemical compounds
GB9100440D0 (en) Chemical compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940316

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

RHK1 Main classification (correction)

Ipc: C07D223/16

A4 Supplementary search report drawn up and despatched

Effective date: 19940705

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19970424

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19981205